Replies to post #38618 on Easton Pharmaceuticals, Inc. (EAPH)

[mckinley1]

EAPH is fine with Production, Marketing, and Distribution of Mexican\Latin American Approved Products as referenced below:

"This approval will support and is expected to add value to on-going formal negotiations with several multi-national pharmaceutical companies, initiated in late 2015 and early 2016. These multi-national pharmaceutical companies are world-wide leaders in providing innovative products in Women's Health and are striving to grow the Latin American segment of their operations by adding VagiSan to their product offerings. The formidable Sales & Marketing strengths of these multinational companies bodes well for the sales potential for VagiSan and the other Women's Health products, AmnioSense and Gynofit, which are also in active discussions with these potential partners."